ArriVent

ArriVent is committed to accelerating the global development of innovative biopharmaceutical products. With a deep global network comprising biotechnology companies and large pharmaceutical firms, ArriVent has access to unique and first-class drug candidates at various stages of development, including those from China and other emerging biotechnology hubs. Through strategic collaborations with innovative biopharmaceutical companies, ArriVent aims to provide globalized medicines for patients with various diseases, initially focusing on oncology.